| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JW-7-52-1 | GDSC1000 | pan-cancer | AAC | -0.056 | 0.3 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.033 | 0.3 |
| mRNA | BI-2536 | FIMM | pan-cancer | AAC | 0.12 | 0.3 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | -0.032 | 0.3 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.4 |
| mRNA | selumetinib:UNC0638 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | -0.031 | 0.4 |